Study shows that Rhizopus arrhizus promotes metabolic steatotic liver cancer by producing kynurenic acid, which activates MAPK signaling, enhancing tumor cell proliferation and accelerating tumor development. https://www.sciencedirect.com/science/article/pii/S1550413126003803 #OpenAccess #mycology #cancer #oncology #microbiology
A study published in The Lancet Oncology estimates that infections caused one in eight new cancer cases worldwide in 2024, with most being associated with the bacterium Helicobacter pylori and the human papillomavirus (HPV), and emphasizes that many of these illnesses could be prevented through measures such as vaccination and screening. #cancer #infectii #preventie (translated)
Nový americký liek daraxonrasib, schválený FDA, sľubuje prelom v liečbe rakoviny pankreasu, pričom pacientom môže predĺžiť život a zlepšiť jeho kvalitu, čo potvrdil aj americký senátor Ben Sasse, ktorý sa uchýlil k experimentálnej terapii po diagnostikovaní metastázujúcej rakoviny. #rakovinapankreasu #oncology #zdravotnictvo
Gynaecological cancers affect too many women and families across Europe. On World Gynecologic Oncology Day, we reaffirm our commitment to act earlier, prevent more & detect sooner, through HPV vaccination, screening and better access to specialised care. #EuropeBeatingCancerPlan https://t.co/3cmGNYo4hI #GynecologicCancer #HPVVaccination #WGO2023 #EU
За мен новината е историческа и намирам, че не е достатъчно отразена. На 19 август 2026 г. Moderna и Merck (MSD) обявиха резултатите от мащабно клинично изпитване във фаза 3: Персонализираната mRNA ваксина срещу меланом (intismeran / mRNA-4157) в комбинация с Keytruda значително намалява риска от връщане и разпространение на рака. Това е първата mRNA противоракова ваксина, която успешно преминава късна фаза на клинични изпитвания. В проучването участваха над 1100 пациенти с висок риск за меланом (стадий IIB–IV), при които туморът е бил напълно отстранен хирургично. Комбинацията ваксина + Keytruda значително удължава времето без рецидив (recurrence-free survival) и намалява риска от поява на далечни метастази в сравнение само с Keytruda. Ваксината е напълно персонализирана - създава се специално за всеки пациент въз основа на уникалните мутации на неговия тумор. Използва се същата mRNA технология, която познаваме от ваксините срещу COVID-19. Това не е просто пореден „пробив в лабораторията“. Това е реална стъпка към нова ера в онкологията. Резултатите вече се наричат „landmark“ (исторически) от водещи онколози. Компаниите планират да подадат документи за одобрение от регулаторите в близките месеци. Ако всичко върви добре, хиляди пациенти могат да се възползват още през 2027 г. Понякога истински революции идват тихо, но променят живота на хиляди хора. #mRNAvaccine #oncology #cancerresearch
Dominik Wolf, Director of the University Clinic for Hematology and Oncology in Innsbruck, emphasizes the importance of colonoscopy as the gold standard for colorectal cancer screening and advocates for a nationwide screening program in Austria to increase early detection and reduce mortality, especially as younger patients are increasingly affected. #Darmkrebs #Vorsorge #Screening
Auf dem Kongress der American Society of Clinical Oncology in Chicago wurden wegweisende Fortschritte in der Krebsbehandlung vorgestellt, darunter neue zielgerichtete Therapien für Bauchspeicheldrüsenkrebs, schwarze Hautkrebs und Brustkrebs, mit vielversprechenden Ergebnissen, die den Patienten individuellere und weniger belastende Behandlungsmöglichkeiten bieten könnten. #Krebsbehandlung #Bauchspeicheldrüsenkrebs #Therapiefortschritte
Presentati al congresso dell’American Society of Clinical Oncology (ASCO) i dati di fase III su daraxonrasib, farmaco sperimentale contro il tumore al pancreas, che ha dato risultati molto promettenti nei test clinici, con una sopravvivenza superiore a un anno nei pazienti trattati, circa il doppio rispetto alla chemioterapia tradizionale. Il medicinale agisce sulle mutazioni del gene KRAS, presenti nella grande maggioranza dei casi di questo tipo di cancro. Gli esperti sottolineano che non si tratta di una cura definitiva, ma di un importante passo avanti nella ricerca contro uno dei tumori più aggressivi al mondo #ASCO2023 #CancroAlPancreas #RicercaMedica
Nová genové testování pro pacientky s hormonálně pozitivním rakovinou prsu, prezentované na kongresu American Society of Clinical Oncology, by mohlo snížit potřebu chemoterapie tím, že určí, kteří pacienti s nízkým rizikem recidivy mohou tuto léčbu vynechat. #borstkanker #chemotherapie #genetischetesten
Enrique Grande, oncólogo y líder del proyecto 'One Oncology' del grupo QuirónSalud en Madrid, aboga por la creación de una red público-privada para mejorar el tratamiento del cáncer, lo que permitiría a los pacientes recibir atención especializada sin importar el hospital, priorizando siempre su acceso a la mejor opción disponible. #Oncología #Cáncer #SaludPública
Deputy Minister of Development Stavros Kalafatis highlighted that Greece produces a significant portion of Europe's oncology (50%), cardio-metabolic (30%), and penicillin (25%) drugs, emphasizing the importance of collaboration between the state, industry, and research sectors in driving innovation and sustainable growth within the healthcare industry. #InnovationInHealthcare #PharmaceuticalIndustry #ResearchAndDevelopment
RT @RogerSeheult: Steven Kornfeld is a hero. The retired oncologist from Bend, Oregon stepped in when the ship’s doctor became ill on the s… #Hero #Oncology #HealthCare #US
The article by Gina Kolata and Rebecca Robbins highlights a breakthrough in the treatment of pancreatic cancer with daraxonrasib, an experimental drug that significantly extends the lives of patients by targeting the KRAS protein, which contributes to various cancers; after decades of failed attempts to develop therapies for this lethal disease, this breakthrough represents a potential paradigm shift in oncology akin to the advent of immunotherapy. #CancerResearch #PancreaticCancer #DrugDevelopment #US
A recent study published in JAMA Oncology reveals that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments due to various barriers such as late diagnoses, access issues, stigma, and a lack of oncologist consultations, despite the availability of promising new therapies that have significantly improved treatment outcomes for this deadly disease. #LungCancer #CancerTreatment #HealthcareAccess #US #CO #TX
A recent study published in JAMA Oncology reveals that over half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments, such as chemotherapy and immunotherapy, due to barriers like late diagnosis, access issues, shame, and fatalism, despite the availability of new drugs that have significantly improved treatment options. #LungCancer #CancerTreatment #HealthEquity #US
A study published in JAMA Oncology reveals that more than half of patients with metastatic lung cancer in the U.S. do not receive potentially life-extending treatments due to various barriers such as diagnostic delays, lack of access to oncologists, and social stigma, despite the availability of new drugs that have significantly improved treatment options. #LungCancer #CancerTreatment #HealthEquity #US
A recent study published in JAMA Oncology revealed that over half of patients with metastatic lung cancer, despite the availability of new, effective treatments, do not receive life-extending therapies due to various barriers such as access issues, late diagnoses, stigma, and lack of oncologist consultations, highlighting a significant gap in care for this deadly disease. #LungCancer #CancerTreatment #HealthcareAccess #US
According to the latest research published by "JAMA Oncology," the HPV vaccine in boys reduces the risk of various types of cancer associated with this pathogen by half. (Original: Z najnowszych badań opublikowanych przez „JAMA Oncology” wynika, że szczepionka przeciwko wirusowi HPV u chłopców o połowę zmniejsza ryzyko wystąpienia związanych z tym patogenem różnego typu nowotworów.) #HPVvaccine #CancerPrevention #PublicHealth #Nospecificcountrycodesarementionedinthearticle.
The oncology service at Barbastro Hospital is facing a critical situation marked by delays, a shortage of specialists, and a perceived abandonment by healthcare authorities, prompting the reactivation of the Platform of Affected Oncology Patients, which calls for urgent staffing changes and the reinstatement of a mixed contract model to ensure continuity of care. #OncologyCare #HealthcareCrisis #PatientAdvocacy #ES
2nd Czech PhD bioinformatics conference started in Křelov near Olomouc with the Abdulrahman Kahraman from NW university Basel about how to hit cancer hard with bioinformatics and precision oncology - especially with alternative splicing analysis 🧬💊🖥️ https://t.co/P3LwMQOMUx #Bioinformatics #CancerResearch #PrecisionOncology
